CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran

CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran

Background: Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (CYP17), affect individuals’ susceptibility to BC. In Iran, the highest incident...

Full description

Bibliographic Details
Main Authors:	Elmira EBRAHIMI, Tayebeh SABOKBAR, Sharareh ESKANDARIEH, Vahideh PEYGHAMBARI, Reza SHIRKOOHI
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2017-04-01
Series:	Iranian Journal of Public Health
Subjects:	Breast cancer CYP17 gene Early onset breast cancer Estrogen Late-onset breast cancer
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/9764

Similar Items

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
by: Piera Rizzolo, et al.
Published: (2019-08-01)

Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age ≥ 70 years: A hospital based-registry study
by: Hyun-June Paik, et al.
Published: (2022-12-01)

The relationship between age of disease onset and prognosis of breast cancer in women
by: Mojtaba Ghaedi, et al.
Published: (2023-02-01)

The Influence of CYP3A4 Polymorphism in Sex Steroids as a Risk Factor for Breast Cancer
by: Melissa Gonzalez Veiga, et al.
Published: (2018-11-01)

Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer
by: Zhiyue Liu, et al.
Published: (2023-06-01)

Identification of differentially expressed genes and splicing events in early-onset colorectal cancer
by: Olivia M. Marx, et al.
Published: (2024-04-01)

Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature
by: Maria da Conceição Barros-Oliveira, et al.
Published: (2021-06-01)

Overview of the genetic basis toward early detection of breast cancer
by: De Silva S, et al.
Published: (2019-01-01)

Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer
by: Fugui Ye, et al.
Published: (2021-01-01)

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
by: Nana Weber-Lassalle, et al.
Published: (2019-04-01)

Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana
by: Patrick Kafui Akakpo, et al.
Published: (2023-01-01)

Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
by: Concetta Blundo, et al.
Published: (2021-08-01)

The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis
by: Angeliki Andrikopoulou, et al.
Published: (2022-01-01)

Polymorphisms of Satellite DNA CYP19 Gene and its Association with Increased Risk of Breast Cancer in Isfahan, Iran
by: Seyed Morteza Javadirad, et al.
Published: (2012-03-01)

Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population
by: Sebastian Morales-Pison, et al.
Published: (2023-02-01)

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
by: Elham Sajjadi, et al.
Published: (2022-07-01)

Different Oncologic Outcomes in Early-Onset and Late-Onset Sporadic Colorectal Cancer: A Regression Analysis on 2073 Patients
by: Caterina Foppa, et al.
Published: (2022-12-01)

The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
by: Robert B. Basmadjian, et al.
Published: (2023-03-01)

Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer
by: Ye Jin Ha, et al.
Published: (2023-04-01)

Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women
by: Marah Tabbal, et al.
Published: (2023-01-01)

Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients
by: Caterina Foppa, et al.
Published: (2023-07-01)

Hormonal and reproductive risk factors in patients with breast cancer
by: Paweł Kalinowski, et al.
Published: (2017-03-01)

Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
by: Murillo-Ortiz B, et al.
Published: (2017-01-01)

Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population
by: Laith N. AL-Eitan, et al.
Published: (2019-09-01)

Understanding the Role of Estrogen Receptor Status in PRODH/POX-Dependent Apoptosis/Survival in Breast Cancer Cells
by: Sylwia Lewoniewska, et al.
Published: (2021-12-01)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
by: Christina Panagiotis Malainou, et al.
Published: (2023-11-01)

The Expression, Morphology, and Clinical Characteristics of Fibroblast Growth Factor-10 in Breast Cancer
by: Samira Molashahi, et al.
Published: (2021-10-01)

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
by: Tú Nguyen-Dumont, et al.
Published: (2018-02-01)

The Unique Biology behind the Early Onset of Breast Cancer
by: Alaa Siddig, et al.
Published: (2021-03-01)

Determining prognostic factors and optimal surgical intervention for early-onset triple-negative breast cancer
by: Yi-Zi Zheng, et al.
Published: (2022-10-01)

Effect of Epidermal Growth Factor in Human Milk and Maternal Diet on Late-Onset Breast Milk Jaundice: A Case-Control Study in Beijing
by: Qianying Guo, et al.
Published: (2022-11-01)

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
by: Jennifer D. Brooks, et al.
Published: (2018-12-01)

Glucocorticoids and breast cancer risk
by: Kelly A. Hirko, et al.
Published: (2021-08-01)

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer
by: Amira Boucenna, et al.
Published: (2022-08-01)

Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China
by: Hongwei Liu, et al.
Published: (2024-04-01)

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer
by: Karin Zins, et al.
Published: (2014-01-01)

Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers
by: Renata Lazari Sandoval, et al.
Published: (2022-03-01)

Endocrine Disruptors and Breast Cancer
by: Cathrin Brisken
Published: (2008-05-01)

Epigenetic factors in breast cancer therapy
by: Runjhun Mathur, et al.
Published: (2022-09-01)

AROMATASE INHIBITORS IN BREAST CANCER THERAPY
by: Hande Karahan, et al.
Published: (2011-04-01)